Heterotypic recognition of recombinant FMDV proteins by bovine T-cells: the polymerase (P3Dpol) as an immunodominant T-cell immunogen.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 9783461)

Published in Virus Res on August 01, 1998

Authors

T Collen1, J Baron, A Childerstone, A Corteyn, T R Doel, M Flint, M Garcia-Valcarcel, R M Parkhouse, M D Ryan

Author Affiliations

1: Department of Immunology, Institute for Animal Health, Pirbright, Surrey, UK. trevor.collen@bbsrc.ac.uk

Articles citing this

A safe foot-and-mouth disease vaccine platform with two negative markers for differentiating infected from vaccinated animals. J Virol (2012) 0.99

Immunosuppression during acute infection with foot-and-mouth disease virus in swine is mediated by IL-10. PLoS One (2009) 0.98

Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol (2006) 0.96

Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95

Foot-and-mouth disease virus exhibits an altered tropism in the presence of specific immunoglobulins, enabling productive infection and killing of dendritic cells. J Virol (2010) 0.85

Identification of major histocompatibility complex restriction and anchor residues of foot-and-mouth disease virus-derived bovine T-cell epitopes. J Virol (2009) 0.82

Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection. PLoS One (2012) 0.81

A pseudotype baculovirus expressing the capsid protein of foot-and-mouth disease virus and a T-cell immunogen shows enhanced immunogenicity in mice. Virol J (2011) 0.80

New vaccine design based on defective genomes that combines features of attenuated and inactivated vaccines. PLoS One (2010) 0.79

Recombinant DNA and Protein Vaccines for Foot-and-mouth Disease Induce Humoral and Cellular Immune Responses in Mice. Immune Netw (2009) 0.78

Articles by these authors

Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol (2001) 4.25

Cost-effectiveness analysis in a setting of budget constraints--is it equitable? N Engl J Med (1996) 4.13

The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol (2001) 3.95

Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol (1997) 3.10

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science (1993) 2.85

Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71

Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39

Candidate for immunoglobulin D present on murine B lymphocytes. Nature (1974) 2.29

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner. J Virol (2004) 2.26

Immunoglobulin M biosynthesis. Intracellular accumulation of 7S subunits. Biochem J (1969) 2.24

A re-appraisal of the biochemical map of foot-and-mouth disease virus RNA. J Gen Virol (1978) 2.06

Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. J Clin Epidemiol (1996) 2.04

Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99

Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study. N Engl J Med (1988) 1.97

The hypotonic upper airway in obstructive sleep apnea: role of structures and neuromuscular activity. Am J Respir Crit Care Med (1998) 1.90

Order of magnitude smaller limit on the electric dipole moment of the electron. Science (2013) 1.89

Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86

Virus-encoded proteinases of the picornavirus super-group. J Gen Virol (1997) 1.86

Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84

The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol (1997) 1.82

The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood (2001) 1.75

An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73

Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest (1994) 1.72

Oral contraceptives and breast cancer: final report of an epidemiological study. Br J Cancer (1983) 1.71

Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology (1994) 1.64

Body size and risk of breast cancer. Am J Epidemiol (1997) 1.63

Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women. Am J Epidemiol (1995) 1.59

Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC. J Immunol (1990) 1.54

The inclusion of patient testimonials in decision aids: effects on treatment choices. Med Decis Making (2001) 1.54

Assembly of immunoglobulin M. Blocked thiol groups of intracellular 7S subunits. Biochem J (1971) 1.53

Methylprednisolone in the management of acute spinal cord injuries. Med J Aust (1990) 1.53

Immunoglobulin M biosynthesis. Production of intermediates and excess of light-chain in mouse myeloma MOPC 104E. Biochem J (1971) 1.51

Purification and identification of the RNA-dependent RNA polymerase of foot-and-mouth disease virus. J Gen Virol (1979) 1.50

Changing proteins on the surface of a parasitic nematode. Nature (1980) 1.50

Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48

Omission bias and pertussis vaccination. Med Decis Making (1994) 1.48

Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44

Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody. J Immunol Methods (1982) 1.43

Depo-Medrol and myelographic arachnoiditis. Med J Aust (1991) 1.43

A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41

Effects of estrogen on growth plate senescence and epiphyseal fusion. Proc Natl Acad Sci U S A (2001) 1.41

Generation of immunoglobulin class diversity in b cells: a discussion with emphasis on idg development. Ann Immunol (Paris) (1976) 1.40

Radioimmunoguided surgery benefits for recurrent colorectal cancer. Ann Surg Oncol (1997) 1.39

Insecticide-induced lupus erythematosus. Int J Dermatol (1994) 1.38

Extrapulmonary tuberculosis in children. Med J Aust (1993) 1.38

Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin D. Nature (1976) 1.38

T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol (1993) 1.37

Regulation of growth plate chondrogenesis by bone morphogenetic protein-2. Endocrinology (2001) 1.37

Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol (1995) 1.35

Effect of 3-amino-1,2,4-triazole on the stimulation of hepatic microsomal heme synthesis and induction of hepatic microsomal oxidases produced by phenobarbital. Mol Pharmacol (1969) 1.35

Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J Biol Chem (2000) 1.34

The colonoscopic miss rate and true one-year recurrence of colorectal neoplastic polyps. Polyp Prevention Study Group. Am J Gastroenterol (1999) 1.33

Phenotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues. Immunology (1996) 1.33

Specific detection of circulating surface/secreted glycoproteins of viable cysticerci in Taenia saginata cysticercosis. Parasite Immunol (1989) 1.32

Self-processing 2A-polyproteins--a system for co-ordinate expression of multiple proteins in transgenic plants. Plant J (1999) 1.31

Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. J Clin Microbiol (2000) 1.31

Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol (1995) 1.31

A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol (1991) 1.31

Structure of mouse Fc receptor. Eur J Immunol (1977) 1.30

Biosynthesis of the carbohydrate portions of immunoglobulin M. Biochem J (1971) 1.29

Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control (1995) 1.27

The role of thrombin in preterm parturition. Am J Obstet Gynecol (2001) 1.26

Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25

Reproductive factors and the risk of brain tumors: a population-based study in Sweden. Int J Cancer (1997) 1.25

A B lymphocyte surface molecule mediating activation and protection from apoptosis via calcium channels. J Immunol (1993) 1.25

Foot-and-mouth disease: the risk for Great Britain after 1992. Vet Rec (1992) 1.25

Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer (1996) 1.24

Tryptic peptide analysis of the structural proteins of vesicular stomatitis virus. J Gen Virol (1978) 1.24

Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. J Gen Virol (1990) 1.23

Enhanced protein synthesis in a cell-free system from hypertrophied skeletal muscle. Science (1967) 1.23

A model for vesicular exanthema virus, the prototype of the calicivirus group. J Gen Virol (1978) 1.22

Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Trans R Soc Trop Med Hyg (1990) 1.22

Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology (1998) 1.22

Thermal stability of foot-and-mouth disease virus. Arch Virol (1981) 1.22

Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1995) 1.20

Immunochemical studies on electron transport chains involving cytochrome P-450. I. Effects of antibodies to pig liver microsomal reduced triphosphopyridine nucleotide-cytochrome c reductase and the non-heme iron protein from bovine adrenocortical mitochondria. J Biol Chem (1971) 1.20

Enabling technologies for manipulating multiple genes on complex pathways. Plant Mol Biol (2001) 1.20

A model for the differentiation of B lymphocytes with implications for the biological role of IgD. Immunol Rev (1977) 1.20

Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine (1990) 1.19

Biosynthesis of immunoglobulin A (IgA) and immunoglobulin M (IgM). Requirement for J chain and a disulphide-exchanging enzyme for polymerization. Biochem J (1973) 1.19

Potent and selective nonpeptide inhibitors of caspases 3 and 7. J Med Chem (2001) 1.18

Foot-and-mouth disease virus particles contain replicase protein 3D. Proc Natl Acad Sci U S A (1994) 1.18

Aortic homograft replacement of the mitral valve in sickle cell trait. J Thorac Cardiovasc Surg (1970) 1.18

Biosynthetic units of an immunoglobulin heavy chain. Proc Natl Acad Sci U S A (1967) 1.18

Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17

Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Trans R Soc Trop Med Hyg (2001) 1.17

Biosynthesis of immunoglobulin A (IgA). Secretion and addition of carbohydrate to monomer and polymer forms of a mouse myeloma protein. Biochem J (1973) 1.17

Failure of cytochalasin or colchicine to inhibit secretion of immunoglobulins. Nat New Biol (1972) 1.17

Intracellular J chain in mouse plasmacytomas secreting IgA, IgM and IgG. Nature (1974) 1.16

Clinical reasoning and cognitive processes. Med Decis Making (1988) 1.16

The non-haemadsorbing African swine fever virus isolate ASFV/NH/P68 provides a model for defining the protective anti-virus immune response. J Gen Virol (2001) 1.15

Risk of breast cancer in relation to lifetime alcohol consumption. J Natl Cancer Inst (1995) 1.14

A new spectral intermediate associated with cytochrome P-450 function in liver microsomes. Biochem Biophys Res Commun (1971) 1.14

Mouse immunoglobulin receptors on lymphocytes: identification of IgM and IgD molecules by tryptic cleavage and a postulated role for cell surface IgD. Eur J Immunol (1977) 1.13

Papain sensitivity of heavy chain sub-classes in normal human IgG and localizaton of antigenic determinants for the sub-classes. Immunochemistry (1971) 1.12

Effect of drugs on heme synthesis in the liver. Metabolism (1971) 1.12

Selective stimulation of IgM synthesis in mouse B lymphocytes by pokeweed mitogen. Nat New Biol (1972) 1.12

Neurological deterioration after reduction of cervical subluxation. Mechanical compression by disc tissue. J Bone Joint Surg Br (1992) 1.11